PubMed:9261375
Annnotations
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 79-84 | protein | denotes | ZEBRA |
| T2 | 106-119 | cell_type | denotes | B lymphocytes |
| T3 | 186-203 | protein | denotes | EBV ZEBRA protein |
| T4 | 205-210 | protein | denotes | ZEBRA |
| T5 | 310-315 | protein | denotes | ZEBRA |
| T6 | 488-493 | protein | denotes | ZEBRA |
| T7 | 526-596 | protein | denotes | heterologous acidic, proline-rich, or glutamine-rich activation domain |
| T8 | 598-603 | protein | denotes | ZEBRA |
| T9 | 645-650 | protein | denotes | ZEBRA |
| T10 | 691-704 | DNA | denotes | EBV promoters |
| T11 | 766-782 | DNA | denotes | EBV lytic origin |
| T12 | 848-853 | protein | denotes | ZEBRA |
| T13 | 856-884 | protein | denotes | N-terminal activation domain |
| T14 | 958-968 | protein | denotes | subdomains |
| T15 | 999-1009 | protein | denotes | N terminus |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-85 | Sentence | denotes | Activation domain requirements for disruption of Epstein-Barr virus latency by ZEBRA. |
| S2 | 86-204 | Sentence | denotes | Latent infection of B lymphocytes by Epstein-Barr virus (EBV) can be disrupted by expression of the EBV ZEBRA protein. |
| S3 | 205-309 | Sentence | denotes | ZEBRA, a transcriptional activator, initiates the EBV lytic cascade by activating viral gene expression. |
| S4 | 310-418 | Sentence | denotes | ZEBRA is also indispensable for viral replication and binds directly to the EBV lytic origin of replication. |
| S5 | 419-487 | Sentence | denotes | The studies described herein demonstrate that the activation domain. |
| S6 | 488-597 | Sentence | denotes | ZEBRA activation can be replaced by a heterologous acidic, proline-rich, or glutamine-rich activation domain. |
| S7 | 598-783 | Sentence | denotes | ZEBRA activation domain swap constructs retain ZEBRA's native abilities to activate specific EBV promoters, to disrupt EBV latency, and to stimulate replication at the EBV lytic origin. |
| S8 | 784-1076 | Sentence | denotes | Additional work, employing sequential and internal deletions of ZEBRA's N-terminal activation domain, indicates that its separate activities are not attributable to specific subdomains but are spread throughout its N terminus and therefore cannot be inactivated by deleting localized regions. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 49-75 | NP | denotes | Epstein-Barr virus latency |
| C2 | 79-84 | NP | denotes | ZEBRA |
| C3 | 205-210 | NP | denotes | ZEBRA |
| C4 | 212-239 | NP | denotes | a transcriptional activator |
| C5 | 310-315 | NP | denotes | ZEBRA |
| C6 | 717-728 | NP | denotes | EBV latency |
| C7 | 784-799 | NP | denotes | Additional work |
| C9 | 848-884 | NP | denotes | ZEBRA's N-terminal activation domain |
| C8 | 801-884 | NP | denotes | employing sequential and internal deletions of ZEBRA's N-terminal activation domain |
| C10 | 901-904 | NP | denotes | its |
| C11 | 995-998 | NP | denotes | its |
| R1 | C3 | C2 | coref-ident | ZEBRA,ZEBRA |
| R2 | C4 | C3 | coref-appos | a transcriptional activator,ZEBRA |
| R3 | C5 | C3 | coref-ident | ZEBRA,ZEBRA |
| R4 | C6 | C1 | coref-ident | EBV latency,Epstein-Barr virus latency |
| R5 | C8 | C7 | coref-ident | employing sequential and internal deletions of ZEBRA's N-terminal activation domain,Additional work |
| R6 | C10 | C9 | coref-pron | its,ZEBRA's N-terminal activation domain |
| R7 | C11 | C9 | coref-pron | its,ZEBRA's N-terminal activation domain |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 49-67 | virus | denotes | Epstein-Barr virus |
| T2 | 79-84 | protein_molecule | denotes | ZEBRA |
| T3 | 106-119 | cell_type | denotes | B lymphocytes |
| T4 | 123-141 | virus | denotes | Epstein-Barr virus |
| T5 | 143-146 | virus | denotes | EBV |
| T6 | 186-189 | virus | denotes | EBV |
| T7 | 190-195 | protein_molecule | denotes | ZEBRA |
| T8 | 205-210 | protein_molecule | denotes | ZEBRA |
| T9 | 255-258 | virus | denotes | EBV |
| T10 | 287-308 | other_name | denotes | viral gene expression |
| T11 | 310-315 | protein_molecule | denotes | ZEBRA |
| T12 | 386-389 | virus | denotes | EBV |
| T13 | 488-493 | protein_molecule | denotes | ZEBRA |
| T14 | 598-603 | protein_molecule | denotes | ZEBRA |
| T15 | 645-650 | protein_molecule | denotes | ZEBRA |
| T16 | 691-694 | virus | denotes | EBV |
| T17 | 717-720 | virus | denotes | EBV |
| T18 | 766-769 | virus | denotes | EBV |
| T19 | 848-853 | protein_molecule | denotes | ZEBRA |
| T20 | 856-884 | protein_domain_or_region | denotes | N-terminal activation domain |
| T21 | 958-968 | protein_domain_or_region | denotes | subdomains |
| T22 | 999-1009 | protein_domain_or_region | denotes | N terminus |